Related references
Note: Only part of the references are listed.Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
Fengqi Zhou et al.
NANO TODAY (2021)
Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy
Qinjun Chen et al.
NANO-MICRO LETTERS (2021)
Enhancing Triple Negative Breast Cancer Immunotherapy by ICG-Templated Self-Assembly of Paclitaxel Nanoparticles
Bing Feng et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Perfluorocarbon nanodroplets stabilized with cisplatin-prodrug-constructed lipids enable efficient tumor oxygenation and chemo-radiotherapy of cancer
Li Yao et al.
NANOSCALE (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Maleimide-thiol adducts stabilized through stretching
Wenmao Huang et al.
NATURE CHEMISTRY (2019)
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy
Bing Feng et al.
ADVANCED MATERIALS (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
Fangyuan Zhou et al.
ADVANCED MATERIALS (2019)
Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Ultrathin Metal-Organic-Layer Mediated Radiotherapy-Radiodynamic Therapy
Kaiyuan Ni et al.
MATTER (2019)
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
Wei Sang et al.
CHEMICAL SOCIETY REVIEWS (2019)
Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
Eun Jung Lee et al.
ADVANCED MATERIALS (2018)
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
Jutaek Nam et al.
NATURE COMMUNICATIONS (2018)
Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
Jinrong Peng et al.
ADVANCED SCIENCE (2018)
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
Bing Feng et al.
ADVANCED MATERIALS (2018)
Targeting the IDO1 pathway in cancer: from bench to bedside
Ming Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Andrew L. Mellor et al.
FRONTIERS IN IMMUNOLOGY (2017)
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Chao Wang et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
Zuqiang Liu et al.
ONCOIMMUNOLOGY (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
C. Lebbe et al.
ANNALS OF ONCOLOGY (2014)
Genentech dives deeper into the next wave of cancer immunotherapies
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mechanisms of Injury to Normal Tissue after Radiotherapy: A Review
Justin R. Hubenak et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
The Spleen in Local and Systemic Regulation of Immunity
Vincenzo Bronte et al.
IMMUNITY (2013)
Enhanced Maturation and Function of Dendritic Cells Using Hydrogel Coated Plate and Antigen Electroporation
Cheol-Hun Son et al.
IMMUNOLOGICAL INVESTIGATIONS (2013)
ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy
Jose Manuel Rodriguez-Vargas et al.
CELL RESEARCH (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
γH2AX: a sensitive molecular marker of DNA damage and repair
L-J Mah et al.
LEUKEMIA (2010)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Creating immune privilege: active local suppression that benefits friends, but protects foes
Andrew L. Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells
J. Rodrigo Mora et al.
SCIENCE (2006)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer
Michael J. Hassett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Photodynamic therapy and anti-tumour immunity
Ana P. Castano et al.
NATURE REVIEWS CANCER (2006)
Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines
SL Hwang et al.
CELL RESEARCH (2005)
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function
RA Colvin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Share Paper
